Asymchem Laboratories (Tianjin) Co., Ltd. Share Price OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded| Market Cap | 57.32B 8.44B 7.41B 6.82B 6.35B 11.98B 802B 12.23B 82B 31.77B 394B 31.68B 30.99B 1,370B | P/E 2026 * |
42.4x | P/E 2027 * | 35.1x |
|---|---|---|---|---|---|
| Enterprise Value | 52.2B 7.68B 6.74B 6.21B 5.79B 10.91B 730B 11.13B 74.67B 28.93B 359B 28.84B 28.22B 1,248B | EV / Sales 2026 * |
6.49x | EV / Sales 2027 * | 5.54x |
| Free-Float |
61.07% | Yield 2026 * |
0.9% | Yield 2027 * | 1.08% |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Hong
CEO | Chief Executive Officer | 70 | 06/10/1998 |
Rui Yang
CEO | Chief Executive Officer | 49 | 18/01/2022 |
Elut Hsu
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Yang
BRD | Director/Board Member | 49 | 17/07/2011 |
Hao Hong
CHM | Chairman | 70 | 06/10/1998 |
Ye Song
BRD | Director/Board Member | 65 | 17/07/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 8.3B | |
| -1.05% | +5.98% | +52.61% | +156.62% | 1,070B | |
| -0.39% | +5.03% | +62.34% | +54.96% | 611B | |
| -0.20% | +6.76% | +31.99% | +85.74% | 445B | |
| -3.05% | +4.18% | +31.11% | +23.88% | 329B | |
| -1.74% | -0.40% | +33.19% | +33.55% | 290B | |
| -1.25% | +0.53% | +27.68% | +41.18% | 287B | |
| +2.99% | +4.00% | -26.09% | -40.14% | 213B | |
| -0.56% | +2.31% | +23.76% | +59.79% | 195B | |
| -0.55% | +0.32% | +12.38% | +63.68% | 157B | |
| Average | -0.47% | +5.04% | +27.66% | +53.25% | 399.58B | |
| Weighted average by Cap. | -0.72% | +6.67% | +38.21% | +78.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.04B 1.18B 1.04B 957M 892M 1.68B 113B 1.72B 11.51B 4.46B 55.25B 4.45B 4.35B 192B | 9.54B 1.4B 1.23B 1.13B 1.06B 1.99B 133B 2.03B 13.65B 5.29B 65.51B 5.27B 5.16B 228B |
| Net income | 1.4B 207M 182M 167M 156M 294M 19.66B 300M 2.01B 779M 9.65B 776M 760M 33.58B | 1.71B 252M 221M 204M 190M 358M 23.95B 365M 2.45B 949M 11.76B 946M 926M 40.92B |
| Net Debt | -5.12B -754M -662M -609M -568M -1.07B -71.69B -1.09B -7.33B -2.84B -35.19B -2.83B -2.77B -122B | -4.5B -662M -581M -535M -498M -940M -62.93B -959M -6.43B -2.49B -30.89B -2.49B -2.43B -108B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
